Therapeutic potential of resveratrol in Alzheimer's disease
2008
Therapeutic potential of resveratrol in Alzheimer's disease
publication
Evidence: moderate
Author Information
Author(s): Vingtdeux Valérie, Dreses-Werringloer Ute, Zhao Haitian, Davies Peter, Marambaud Philippe
Primary Institution: Litwin-Zucker Research Center for the Study of Alzheimer's Disease, The Feinstein Institute for Medical Research
Hypothesis
Can resveratrol have neuroprotective effects against Alzheimer's disease?
Conclusion
Resveratrol may have therapeutic potential in Alzheimer's disease by promoting anti-amyloidogenic mechanisms.
Supporting Evidence
- Epidemiological studies suggest that moderate red wine consumption is linked to lower Alzheimer's disease risk.
- Resveratrol has shown neuroprotective properties in rodent models.
- Resveratrol may promote the clearance of amyloid-beta, a key factor in Alzheimer's disease pathology.
Takeaway
Drinking red wine, which contains a substance called resveratrol, might help protect the brain from Alzheimer's disease.
Limitations
The bioavailability of unmodified resveratrol is low, which may limit its therapeutic potential.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website